FOCUSEDONATTENTION Trademark

Trademark Overview

On Thursday, September 14, 2017, a trademark application was filed for FOCUSEDONATTENTION with the United States Patent and Trademark Office. The USPTO has given the FOCUSEDONATTENTION trademark a serial number of 87608559. The federal status of this trademark filing is REGISTERED as of Tuesday, November 2, 2021. This trademark is owned by KemPharm, Inc.. The FOCUSEDONATTENTION trademark is filed in the Computer & Software Services & Scientific Services category with the following description:

Providing educational information in the field of new product research and development, medical clinical trial research, medical laboratories and medical research, and pharmaceutical research and development; Providing a website featuring educational information in the field of new product research and development, medical clinical trial research, medical laboratories and medical research, and pharmaceutical research and development
focusedonattention

General Information

Serial Number87608559
Word MarkFOCUSEDONATTENTION
Filing DateThursday, September 14, 2017
Status700 - REGISTERED
Status DateTuesday, November 2, 2021
Registration Number6547910
Registration DateTuesday, November 2, 2021
Mark Drawing4000 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, July 31, 2018

Trademark Statements

Pseudo MarkFOCUSED ON ATTENTION
Goods and ServicesProviding educational information in the field of new product research and development, medical clinical trial research, medical laboratories and medical research, and pharmaceutical research and development; Providing a website featuring educational information in the field of new product research and development, medical clinical trial research, medical laboratories and medical research, and pharmaceutical research and development

Classification Information

International Class042 - Scientific and technological services and research and design relating thereto; industrial analysis and research services; design and development of computer hardware and software.
US Class Codes100, 101
Class Status Code6 - Active
Class Status DateTuesday, June 19, 2018
Primary Code042
First Use Anywhere DateWednesday, September 22, 2021
First Use In Commerce DateWednesday, September 22, 2021

Trademark Owner History

Party NameZEVRA THERAPEUTICS, INC.
Party Type31 - New Owner After Registration
Legal Entity Type03 - Corporation
AddressCELEBRATION, FL 34747
Party NameKemPharm, Inc.
Party Type30 - Original Registrant
Legal Entity Type03 - Corporation
AddressCelebration, FL 34747
Party NameKemPharm, Inc.
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressCelebration, FL 34747
Party NameKemPharm, Inc.
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressCoralville, IA 52241

Trademark Events

Event DateEvent Description
Wednesday, December 6, 2023TEAS CHANGE OF CORRESPONDENCE RECEIVED
Wednesday, December 6, 2023ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Wednesday, December 6, 2023TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Wednesday, December 6, 2023APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
Wednesday, December 6, 2023TEAS CHANGE OF OWNER ADDRESS RECEIVED
Wednesday, November 22, 2023AUTOMATIC UPDATE OF ASSIGNMENT OF OWNERSHIP
Tuesday, November 2, 2021REGISTERED-PRINCIPAL REGISTER
Friday, October 1, 2021NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED
Thursday, September 30, 2021ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
Wednesday, September 29, 2021STATEMENT OF USE PROCESSING COMPLETE
Friday, September 24, 2021USE AMENDMENT FILED
Friday, September 24, 2021TEAS STATEMENT OF USE RECEIVED
Friday, April 9, 2021NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Thursday, April 8, 2021SOU EXTENSION 5 GRANTED
Thursday, March 25, 2021SOU EXTENSION 5 FILED
Thursday, April 8, 2021CASE ASSIGNED TO INTENT TO USE PARALEGAL
Thursday, March 25, 2021SOU TEAS EXTENSION RECEIVED
Tuesday, September 29, 2020NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Friday, September 25, 2020SOU EXTENSION 4 GRANTED
Friday, September 25, 2020SOU EXTENSION 4 FILED
Friday, September 25, 2020SOU TEAS EXTENSION RECEIVED
Friday, March 27, 2020NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Wednesday, March 25, 2020SOU EXTENSION 3 GRANTED
Wednesday, March 25, 2020SOU EXTENSION 3 FILED
Wednesday, March 25, 2020SOU TEAS EXTENSION RECEIVED
Friday, September 27, 2019NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Wednesday, September 25, 2019SOU EXTENSION 2 GRANTED
Wednesday, September 25, 2019SOU EXTENSION 2 FILED
Wednesday, September 25, 2019SOU TEAS EXTENSION RECEIVED
Tuesday, April 30, 2019APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
Tuesday, April 30, 2019TEAS CHANGE OF OWNER ADDRESS RECEIVED
Wednesday, March 27, 2019NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Monday, March 25, 2019SOU EXTENSION 1 GRANTED
Monday, March 25, 2019SOU EXTENSION 1 FILED
Monday, March 25, 2019SOU TEAS EXTENSION RECEIVED
Tuesday, September 25, 2018NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Tuesday, July 31, 2018OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, July 31, 2018PUBLISHED FOR OPPOSITION
Wednesday, July 11, 2018NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Tuesday, June 26, 2018APPROVED FOR PUB - PRINCIPAL REGISTER
Tuesday, June 19, 2018TEAS/EMAIL CORRESPONDENCE ENTERED
Monday, June 18, 2018CORRESPONDENCE RECEIVED IN LAW OFFICE
Monday, June 18, 2018TEAS RESPONSE TO OFFICE ACTION RECEIVED
Thursday, December 21, 2017APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
Thursday, December 21, 2017TEAS CHANGE OF OWNER ADDRESS RECEIVED
Tuesday, December 19, 2017NOTIFICATION OF NON-FINAL ACTION E-MAILED
Tuesday, December 19, 2017NON-FINAL ACTION E-MAILED
Tuesday, December 19, 2017NON-FINAL ACTION WRITTEN
Tuesday, December 19, 2017ASSIGNED TO EXAMINER
Wednesday, September 20, 2017NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Monday, September 18, 2017NEW APPLICATION ENTERED

Related Keywords

focusedonattention research medical development trial laboratories pharmaceutical field clinical product educational